HTG Molecular Diagnostics Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
107
- Stock Symbol
-
HTGMQ
HTG Molecular Diagnostics General Information
Description
HTG Molecular Diagnostics Inc is a life science company whose mission is to advance precision medicine through its transcriptome-wide profiling and medicinal chemistry technologies. The company derives revenue from sales of its HTG EdgeSeq system and integrated next-generation sequencing-based HTG EdgeSeq research use only assays and from sample processing services performed in its VERI/O laboratory. The company operates in one segment and its customers and distributors are located in the United States and Europe.
Contact Information
Website
www.htgmolecular.comCorporate Office
- 3430 East Global Loop
- Tucson, AZ 85706
- United States
Corporate Office
- 3430 East Global Loop
- Tucson, AZ 85706
- United States
HTG Molecular Diagnostics Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 2.82K |
HTG Molecular Diagnostics Financials Summary
As of 31-Mar-2023, HTG Molecular Diagnostics has a trailing 12-month revenue of $6.21M.
|
In Thousands, USD |
TTM 31-Mar-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | (1,399) | 3,604 | 27,548 | 4,754 |
| Revenue | 6,214 | 6,366 | 8,907 | 8,549 |
| EBITDA | (19,092) | (20,234) | (15,367) | (18,739) |
| Net Income | (20,152) | (21,594) | (17,145) | (20,870) |
| Total Assets | 10,866 | 17,778 | 30,461 | 35,198 |
| Total Debt | 3,981 | 4,834 | 11,710 | 12,644 |
HTG Molecular Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
HTG Molecular Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
HTG Molecular Diagnostics Comparisons
Industry
Financing
Details
HTG Molecular Diagnostics Competitors (16)
One of HTG Molecular Diagnostics’s 16 competitors is SeraCare, a Formerly PE-Backed company based in Milford, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SeraCare | Formerly PE-Backed | Milford, MA | ||||
| CIS Bio International | Formerly PE-Backed | Saclay, France | ||||
| ABM (Canada) | Corporation | Richmond, Canada | ||||
| Oxford Gene Technology | Formerly VC-backed | Kidlington, United Kingdom | ||||
| Bio-Techne | Corporation | Minneapolis, MN |
HTG Molecular Diagnostics Patents
HTG Molecular Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024145483-A1 | Compounds for use in the treatment of cancer and methods of making and using the same | Inactive | 28-Dec-2022 | ||
| US-20240425914-A1 | Epitranscriptome evaluation | Pending | 01-Sep-2021 | ||
| WO-2023034747-A1 | Epitranscriptome evaluation | Inactive | 01-Sep-2021 | ||
| WO-2023034747-A9 | Epitranscriptome evaluation | Inactive | 01-Sep-2021 | ||
| AU-2019418340-A1 | Methods of detecting dna and rna in the same sample | Inactive | 31-Dec-2018 | C12Q1/6874 |
HTG Molecular Diagnostics Signals
HTG Molecular Diagnostics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
HTG Molecular Diagnostics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
HTG Molecular Diagnostics FAQs
-
When was HTG Molecular Diagnostics founded?
HTG Molecular Diagnostics was founded in 1997.
-
Where is HTG Molecular Diagnostics headquartered?
HTG Molecular Diagnostics is headquartered in Tucson, AZ.
-
What is the size of HTG Molecular Diagnostics?
HTG Molecular Diagnostics has 107 total employees.
-
What industry is HTG Molecular Diagnostics in?
HTG Molecular Diagnostics’s primary industry is Discovery Tools (Healthcare).
-
Is HTG Molecular Diagnostics a private or public company?
HTG Molecular Diagnostics is a Public company.
-
What is HTG Molecular Diagnostics’s stock symbol?
The ticker symbol for HTG Molecular Diagnostics is HTGMQ.
-
What is HTG Molecular Diagnostics’s current revenue?
The trailing twelve month revenue for HTG Molecular Diagnostics is $6.21M.
-
Who are HTG Molecular Diagnostics’s competitors?
SeraCare, CIS Bio International, ABM (Canada), Oxford Gene Technology, and Bio-Techne are some of the 16 competitors of HTG Molecular Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process